Neither NAD+ nor NADH supplements have enough clinical evidence to recommend them broadly for healthy adults. NAD+ levels do decline with age, and that decline is linked to metabolic and cellular problems, but swallowing the molecule itself is not a straightforward fix. Both NAD+ and NADH face serious bioavailability hurdles in the gut, and the handful of human trials that exist are small, short, and often underwhelming compared to the animal research that generated the hype. The picture gets more interesting when you look at precursor molecules like NMN and NR, but even there, the human data lags far behind the marketing.
Why NAD+ Matters in the First Place
NAD+ is a molecule your cells use constantly. It shuttles electrons during the chemical reactions that turn food into energy, and it serves as fuel for several families of enzymes involved in DNA repair, inflammation control, and gene regulation.1PubMed Central. NAD(H) and NADP(H) Redox Couples and Cellular Energy Metabolism NADH is simply the “spent” form of NAD+ after it has picked up an electron. Your body cycles back and forth between the two forms thousands of times a day. The enzymes that depend on NAD+ include sirtuins and PARPs, both of which are tied to aging, stress responses, and cellular maintenance.2PubMed Central. NAD+ and sirtuins in aging and disease When NAD+ levels drop, these enzymes have less fuel, and the downstream effects touch everything from mitochondrial function to inflammatory signaling.
The Age-Related Decline That Drives the Hype
Research in mice has shown that NAD+ levels fall substantially with age, driven in part by rising activity of an enzyme called CD38. In one study, CD38 levels increased two- to threefold across multiple tissues in aging mice, and CD38 mRNA went up roughly 2.5 times in liver, fat, and muscle, and up to sixfold in the spleen.3PubMed Central. CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism The resulting NAD+ shortage was linked to mitochondrial dysfunction through reduced sirtuin activity. This is the core narrative behind the supplement industry’s pitch: aging depletes NAD+, so replacing it should slow or reverse the process. The logic is tidy, but the jump from mouse biology to a capsule you buy online skips over some major gaps.
What Happens When You Swallow NAD+ or NADH
The biggest problem with taking NAD+ or NADH directly is that your digestive system is not gentle with them. A study comparing oral versus injected NAD+ and NADH in rats found that oral NADH did not increase urinary levels of nicotinamide or its breakdown products the way oral NAD+ or nicotinamide did. When researchers incubated NADH at the acidic pH of stomach fluid, it rapidly converted into an unknown compound that could not generate nicotinamide.4Journal of Nutritional Science and Vitaminology. Comparison of Metabolic Fates of Nicotinamide, NAD+ and NADH Administered Orally and Intraperitoneally; Characterization of Oral NADH In plain terms, NADH appears to be destroyed by stomach acid before it can do much of anything. NAD+ itself fares somewhat better but still gets broken down into smaller components, primarily nicotinamide, before absorption. You are not absorbing intact NAD+ molecules into your bloodstream; your gut dismantles them first.
This is why the supplement conversation has largely shifted toward NAD+ precursors, molecules like nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN), which survive digestion better and get converted into NAD+ inside cells. Oral supplementation with NR and NMN does reliably raise blood NAD+ levels in humans, though the effect has been smaller than what animal studies predicted.5Food Frontiers. An Updated Review on the Mechanisms, Pre‐Clinical and Clinical Comparisons of Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR)
The Human Evidence for NADH Supplements
NADH has been tested in a handful of clinical trials, mostly for chronic fatigue syndrome (CFS). In one early crossover trial of 26 CFS patients, about 31% responded favorably to NADH compared with 8% on placebo.6PubMed. Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome That sounds promising until you notice the tiny sample size, which makes the results fragile. A later Spanish trial found no significant differences between NADH and placebo on most outcomes, though the NADH group did show a modest decrease in anxiety scores and a small drop in maximum heart rate after a stress test.7PubMed. Nicotinamide adenine dinucleotide (NADH) in patients with chronic fatigue syndrome A third trial combined NADH (20 mg per day) with CoQ10 (200 mg per day) and found a significant improvement in fatigue scores along with better cellular energy markers, but the combined design makes it impossible to know how much NADH alone contributed.8PubMed Central. Does oral coenzyme Q10 plus NADH supplementation improve fatigue and biochemical parameters in chronic fatigue syndrome?
NADH has also been explored for Parkinson’s disease. An open-label study of 885 patients reported that roughly 80% showed some degree of improvement in disability, with about 19% showing a 30–50% reduction and 59% showing a 10–30% reduction. The oral form performed comparably to intravenous NADH.9PubMed. Nicotinamide adenine dinucleotide (NADH)–a new therapeutic approach to Parkinson’s disease. Comparison of oral and parenteral application A smaller study of 15 Parkinson’s patients receiving intravenous NADH found significant improvement on a standard disability scale and increased blood levels of levodopa, suggesting NADH might stimulate the body’s own production of the neurotransmitter precursor.10PubMed. Parenteral application of NADH in Parkinson’s disease: clinical improvement partially due to stimulation of endogenous levodopa biosynthesis These are intriguing results, but both studies were open-label, meaning neither patients nor doctors were blinded, which inflates the apparent benefit. No large, randomized, placebo-controlled trial has followed up on these findings.
Taken together, the human evidence for NADH supplements is thin and dated. A few small trials show hints of benefit for specific conditions, but nothing approaching the standard you would need to recommend it confidently.
NAD+ Precursors Have More Data, but Still Not Enough
NMN and NR have attracted far more research funding and clinical attention than direct NAD+ or NADH supplements. Their advantage is better oral bioavailability: they survive the gut, enter the bloodstream, and get converted into NAD+ inside cells. Both have been shown to raise NAD+ levels in human studies, though the downstream health effects remain uncertain for most people.
The most notable human trial to date gave NMN to postmenopausal women with prediabetes who were overweight or obese. After ten weeks, the NMN group showed improved muscle insulin sensitivity, increased insulin signaling, and changes in gene expression related to muscle remodeling, while the placebo group did not.11PubMed Central. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women That is a real, measurable metabolic change in a population at risk for diabetes. But it is one small study in a narrow population, and it does not tell you whether NMN would benefit a healthy 35-year-old.
A systematic review covering studies of NAD+, NADH, and various precursors found that supplementation was generally well tolerated, with common side effects limited to muscle pain, sleep disturbance, headaches, and fatigue, none of which posed serious health risks.12PubMed. Evaluation of safety and effectiveness of NAD in different clinical conditions: a systematic review That same review noted improvements in anxiety, heart rate, inflammatory markers, and general quality of life across various studies, but none of the individual trials were large enough to be definitive.
Athletic Performance and Exercise
If you are considering NAD+ supplements to boost workout performance or recovery, the evidence is discouraging. A review in Sports Medicine concluded that despite promising results in cell and rodent studies, NAD+ therapeutics have not translated into benefits for skeletal muscle adaptation or athletic performance in humans. The review found that NAD+ metabolism in muscle appears tightly regulated, with limited evidence that NAD+ deficiency occurs in the physiological scenarios most relevant to athletes and exercisers.13PubMed Central. NAD+ Therapeutics and Skeletal Muscle Adaptation to Exercise in Humans The exception might be someone with a clear NAD+ deficiency, but that is not the typical person buying supplements for gym gains.
Brain Health and Cognitive Function
The brain health angle is where the animal data is most exciting and the human data most lacking. In mouse models of Alzheimer’s disease, supplementing with NR normalized the brain’s NAD+ balance, improved cognitive performance across multiple behavioral tests, and restored the ability of neurons to strengthen their connections.14PubMed Central. NAD(+) supplementation normalizes key Alzheimer’s features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency In a rat model of reduced blood flow to the brain, NAD+ administration rescued cognitive deficits and reduced neuroinflammation by protecting mitochondria.15PubMed Central. NAD+ improves cognitive function and reduces neuroinflammation by ameliorating mitochondrial damage and decreasing ROS production in chronic cerebral hypoperfusion models through Sirt1/PGC-1α pathway
A review summarizing the state of the field noted that preserving cognitive ability by raising NAD+ has been identified as a promising strategy for age-related cognitive decline, stroke, diabetes-related brain damage, and traumatic brain injury, but acknowledged that the findings are “mostly positive” while being “made primarily in animal models, with some reports of null or adverse effects.”16PubMed Central. Supplementation with NAD+ and Its Precursors to Prevent Cognitive Decline across Disease Contexts In other words, the biological story is coherent, but no one has yet run the definitive human trial showing that taking NMN or NR prevents dementia or sharpens memory in aging adults.
The Cancer Concern Worth Knowing About
This is the part most supplement marketers leave out. Cancer cells are metabolically hungry, and NAD+ fuels the energy pathways they rely on. The enzyme that makes NAD+ in cells (called NAMPT) is frequently overproduced in several types of cancer, and blocking that enzyme depletes NAD+ and suppresses cancer cell growth.17PubMed Central. NAD Metabolism in Cancer Therapeutics This creates an uncomfortable tension: flooding your body with NAD+ might help healthy cells but could theoretically feed existing tumors or pre-cancerous cells you do not know about.
A review of the interplay between NAD+ and cellular aging warned that increasing NAD+ levels, whether through supplements or genetic manipulation, may benefit tissue maintenance while also worsening the inflammatory signals that senescent cells produce and encouraging tumor formation, at least in mouse cancer models.18PubMed. Interacting NAD(+) and Cell Senescence Pathways Complicate Antiaging Therapies No human study has shown that NAD+ supplements cause cancer, and the concern remains theoretical. But it represents a genuine biological trade-off that is not resolved by existing research. If you have a personal or family history of cancer, this is worth discussing with your doctor before starting supplementation.
NADH Stability Is a Practical Problem
Beyond the bioavailability question, NADH as a supplement has a shelf-life problem. The molecule is chemically unstable and degrades over time, especially in the presence of heat, moisture, or certain buffer conditions. Laboratory measurements have shown that NADH breaks down at rates that vary with temperature and chemical environment, with higher temperatures and phosphate-based conditions accelerating decomposition substantially. Even under favorable conditions at room temperature, a meaningful fraction of the NADH in a capsule may no longer be intact by the time you take it, depending on how it was manufactured and stored. Manufacturers of stabilized NADH formulations use enteric coatings and special packaging to slow this degradation, but these add cost and are difficult for consumers to verify.
Sublingual and IV Delivery
Some people try to get around the digestion problem by using sublingual (under-the-tongue) tablets or IV infusions. IV NAD+ drips, popular in longevity clinics, bypass the gut entirely and deliver the molecule directly into the bloodstream, but they are expensive, time-consuming, and not well studied for long-term safety or efficacy. Sublingual delivery of NMN has been tested in a small study of healthy men, which found that while certain breakdown products appeared in the blood faster with sublingual delivery than with oral, the actual blood levels of NMN, NAD+, and other key metabolites did not differ between the two methods.19PubMed Central. Vitamin B3 Ameliorates Sleep Duration and Quality in Clinical and Pre-Clinical Studies – Section: 3.3. Impacts of NR Supplementation on Circadian Rhythms and Genetic Mechanisms So the sublingual route might speed up initial processing without actually raising NAD+ levels any more than swallowing a capsule does.
NAD+, Sirtuins, and Your Internal Clock
One of the more genuinely interesting areas of NAD+ biology is its connection to circadian rhythms. Your body’s internal clock depends partly on a feedback loop involving sirtuins, and since sirtuins need NAD+ to function, the two systems are intertwined. Research has shown that NAD+ and the sirtuin SIRT1 regulate core clock proteins, including one called PER2, controlling where it goes inside cells, how stable it is, and how it interacts with DNA.20Molecular Cell. NAD+ Controls Circadian Reprogramming through SIRT1 to Control Circadian Clocks and Aging In animal experiments, NR supplementation increased NAD+ levels four- to fivefold in muscle and brain tissue and enhanced the binding activity of BMAL1, another clock protein, across the genome.19PubMed Central. Vitamin B3 Ameliorates Sleep Duration and Quality in Clinical and Pre-Clinical Studies – Section: 3.3. Impacts of NR Supplementation on Circadian Rhythms and Genetic Mechanisms
The implication is that declining NAD+ with age could contribute to the disrupted sleep and circadian rhythm problems that become more common in older adults. Whether supplementation can meaningfully restore those rhythms in humans is an open question, but the mechanistic link is well established in laboratory settings.
Testing Your Own NAD+ Levels
One frustration in this space is the difficulty of knowing where you stand before deciding to supplement. Most people taking NAD+ boosters have no idea whether their levels are actually low. A study developing a rapid blood test for NAD+ highlighted that the lack of cheap, accessible assays has limited our ability to establish baseline NAD+ levels across populations and to personalize supplementation strategies, especially for people who respond poorly to standard doses.21PubMed Central. Fingerstick blood assay maps real‐world NAD+ disparity across gender and age Without knowing your starting point, you are essentially guessing about whether supplementation will help, and there is no reliable consumer test widely available yet. Some longevity clinics offer NAD+ blood panels, but standardized reference ranges are still being established. This means the entire supplement market is built on a population-level observation (NAD+ falls with age) being applied as individual health advice, without verifying whether each individual actually has a shortfall.
Who Might Reasonably Consider These Supplements
Given everything above, the people with the strongest case for trying NAD+ precursors are those with conditions where NAD+ depletion has been documented or where small trials have shown potential benefit. That includes older adults experiencing metabolic decline, people with chronic fatigue syndrome who have tried conventional approaches, and possibly individuals with early-stage neurodegenerative disease, though only in conversation with their neurologist. The systematic review evidence supports that supplementation is safe with a low incidence of side effects, so the risk of trying is modest for most people.12PubMed. Evaluation of safety and effectiveness of NAD in different clinical conditions: a systematic review
For healthy younger adults hoping to slow aging or improve performance, the rationale is much weaker. Your body already maintains NAD+ levels reasonably well when you are young, and adding more through supplements has not been shown to push things above baseline in a way that produces measurable health benefits. Exercise, adequate sleep, and caloric moderation all support NAD+ metabolism through natural pathways, and these interventions have far more evidence behind them than any capsule. If you do decide to supplement, NMN or NR are better-supported choices than direct NAD+ or NADH, given the bioavailability issues with the latter two. Look for third-party-tested products, store them properly, and keep your expectations calibrated to the current state of the science rather than the aspirational narratives common in the longevity community.